Results 261 to 270 of about 5,061,790 (379)

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Naringin attenuates angiotensin II induced cardiac hypertrophy by inhibiting carbonic anhydrase II. [PDF]

Sci Rep
Mahadevaswamy M, Suchitha GP, Pavan SR, Vivek HK, Nithya SD, Chandan S, Prasad SK, Keshava Prasad TS, Ahmad SF, Attia SM, Dagamajalu S, Siddesha JM.   +11 more
europepmc   +1 more source

The effect of altered sodium balance upon renal vascular reactivity to angiotensin II and norepinephrine in the dog. Mechanism of variation in angiotensin responses. [PDF]

, 1978
Juan Oliver, Paul J. Cannon
openalex   +1 more source

Socio‐economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis

ESC Heart Failure, Volume 12, Issue 2, Page 927-941, April 2025.
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor, Willemijn A. van Maarschalkerwaart, Jeroen Schaap, Rudolf A. de Boer, Nicolas M. van Mieghem, Eric H. Boersma, Loek van Heerebeek, Jasper J. Brugts, Robert M.A. van der Boon   +8 more
wiley   +1 more source

Author Correction: Naringin attenuates angiotensin II induced cardiac hypertrophy by inhibiting carbonic anhydrase II. [PDF]

Sci Rep
Mahadevaswamy M, Suchitha GP, Pavan SR, Vivek HK, Nithya SD, Chandan S, Prasad SK, Keshava Prasad TS, Ahmad SF, Attia SM, Dagamajalu S, Siddesha JM.   +11 more
europepmc   +1 more source

Angiotensin II Receptors in Bovine Adrenal Cortex

, 1974
Hartmut Glossmann, Albert J. Baukal, Kevin Catt   +2 more
openalex   +1 more source

Inhibitors of the renin‐angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting‐enzyme inhibitor. [PDF]

, 1979
JJ Morton, J. Casals‐Stenzel, A. F. Lever, JA Millar, A. J. G. Riegger, M. Tree   +5 more
openalex   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

CD248 deficiency promotes angiotensin II-induced aortic lesion by attenuating receptor stability in smooth muscle cells. [PDF]

Clin Transl Med
Hsieh TT, Ku YC, Chen CJ, Kuo CH, Chang BI, Yu CH, Li YH, Tsai PJ, Lin SW, Wu HL, Luo CY, Tsai YS.   +11 more
europepmc   +1 more source

The effect of angiotensin II on the platelet aggregation induced by adenosine-diphosphate, epinephrine and thrombin [PDF]

, 1970
A Popławski
openalex   +1 more source